Company Analysis ShockWave Medical, Inc.
1. Summary
Advantages
- The stock's return over the last year (0%) is higher than the sector average (-20.93%).
Disadvantages
- Price (330.7 $) is higher than fair price (69.16 $)
- Dividends (0%) are below the sector average (0.53%).
- Current debt level 46.95% has increased over 5 years from 9.19%.
- The company's current efficiency (ROE=22.03%) is lower than the sector average (ROE=104.34%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| ShockWave Medical, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -21.4% | -0.1% |
| 90 days | 0% | -23.4% | 4.8% |
| 1 year | 0% | -20.9% | 21.2% |
SWAV vs Sector: ShockWave Medical, Inc. has outperformed the "Healthcare" sector by 20.93% over the past year.
SWAV vs Market: ShockWave Medical, Inc. has significantly underperformed the market by -21.22% over the past year.
Stable price: SWAV is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SWAV with weekly volatility of 0% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (330.7 $) is higher than the fair price (69.16 $).
Price is higher than fair: The current price (330.7 $) is 79.1% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (50.2) is higher than that of the sector as a whole (35.84).
P/E vs Market: The company's P/E (50.2) is higher than that of the market as a whole (-65.92).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (11.06) is lower than that of the sector as a whole (254.49).
P/BV vs Market: The company's P/BV (11.06) is lower than that of the market as a whole (51.09).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (10.13) is lower than that of the sector as a whole (127.81).
P/S vs Market: The company's P/S indicator (10.13) is lower than that of the market as a whole (147.92).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (44.43) is higher than that of the sector as a whole (-27.35).
EV/Ebitda vs Market: The company's EV/Ebitda (44.43) is higher than that of the market as a whole (-94.27).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -343.69% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-343.69%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1802.65%).
6.4. ROE
ROE vs Sector: The company's ROE (22.03%) is lower than that of the sector as a whole (104.34%).
ROE vs Market: The company's ROE (22.03%) is higher than that of the market as a whole (-6.17%).
6.6. ROA
ROA vs Sector: The company's ROA (9.4%) is higher than that of the sector as a whole (-2.2%).
ROA vs Market: The company's ROA (9.4%) is lower than that of the market as a whole (38.35%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (10.97%) is higher than that of the sector as a whole (1.17%).
ROIC vs Market: The company's ROIC (10.97%) is higher than that of the market as a whole (9.59%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.53%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (4.23%) are at an uncomfortable level.
9. Insider trades
9.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
9.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 06.03.2024 | Phung Trinh VP, Finance |
Sale | 253.14 | 5 316 | 21 |
| 22.02.2024 | Phung Trinh VP, Finance |
Sale | 259.24 | 155 285 | 599 |
| 21.02.2024 | MOLL FREDERIC H Director |
Sale | 257.39 | 15 443 400 | 60 000 |
| 15.02.2024 | Godshall Douglas Evan President & CEO |
Sale | 231.56 | 2 315 600 | 10 000 |
| 15.02.2024 | Godshall Douglas Evan President & CEO |
Purchase | 3.42 | 34 200 | 10 000 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
